Changes in hepatitis B virus surface antibody titer and risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients undergoing biologic therapy for rheumatic diseases: a prospective cohort study

BACKGROUND: Our aim was to investigate dynamic changes in hepatitis B virus (HBV) surface antibody (HBsAb) titer and the associated risk of HBV reactivation and clinical course in patients with HBV surface antigen negative/core antibody positive (HBsAg(−)/HBcAb(+)) serostatus during antirheumatic th...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Arthritis Res Ther
Autores principales: Tien, Ya-Chih, Yen, Hsu-Heng, Li, Ching-Fang, Liu, Mei-Ping, Hsue, Yin-Tzu, Hung, Ming-Hui, Chiu, Ying-Ming
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6235201/
https://ncbi.nlm.nih.gov/pubmed/30382902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-018-1748-z
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares